Type
|
Public |
---|---|
Traded as | NASDAQ: CTRP NASDAQ-100 Component |
Industry | Travel agency |
Founded | 1999 (IPO December 9, 2003) |
Headquarters | Shanghai, China |
Key people
|
Sun Jie (Jane Sun, CEO |
Products | accommodation, ticketing, tours |
Revenue |
|
Number of employees
|
30,000 |
Website | www.ctrip.com |
Ctrip is a Chinese provider of travel services including accommodation reservation, transportation ticketing, packaged tours and corporate travel management.
Shanghai-based Ctrip was founded by James Liang, Neil Shen, Min Fan, and Qi Ji in 1999. It listed on NASDAQ in 2003 in a Merrill Lynch-led offering, raising US$75 million (4.2 million ADRs at $18 each) and then further appreciated by 86% to close at $33.94 in its first day of trading. Ctrip traded at a peak of $37.35, making it the first company since the November 2000 IPO of Transmeta to double its price in the first day of trading.
In 2006, about 70% of Ctrip's sales came from just four cities in China: Beijing, Guangzhou, Shanghai, and Shenzhen.
In December 2013, Ctrip acquired the American travel company Tours4fun for over $100 million.
In May 2015, The Priceline Group announced it would be investing an additional $250 million in the company.
In November 2016, Ctrip acquired the Scottish travel company Skyscanner and appointed new CEO Jane Jie Sun.
Ctrip enjoyed spectular growth in recent years. In 2015, Ctrip's net revenues were RMB 10.9 billion (USD 1.7 billion), up 48% year-on-year. In 2016, its net revenue grow 76% year-on-year to RMB19.2 billion (USD 2.9 billion).
In 2006, Liang spoke to Bloomberg about the possibility of Ctrip buying travel companies in other Asian markets such as Hong Kong and South Korea. Ctrip already had an agreement with Taiwan-based ezTravel to cooperate in offering air tickets and hotel rooms to mainland Chinese tourists in Taiwan once tourists from the mainland became able to travel to Taiwan. As of November 2011, Ctrip holds an 8.4% stake in NASDAQ-listed Home Inns as well as a minority stake in the privately held BTC-Jianguo Hotels and Resorts. Ctrip also holds a 1.3% stake in the NASDAQ-listed China Lodging (owner of the Hanting brand). On August 6, 2014, Priceline.com, announced that it will invest $500 million in Ctrip.com International Ltd. to broaden the companies’ options in China. Priceline and Ctrip, which have had a commercial partnership since 2012, will increase their cross-promotion of each company’s hotel inventory and other travel services, the companies said today in a statement. As of November 2016, Ctrip owns both Scottish travel site Skyscanner and American-based travel site Tours4fun.
Ctrip is recognized as a proponent of scientific management in using rigorous data analysis in managerial decision making. One example of this is the randomized control trial Ctrip ran on telecommuting. Given the uncertainty over the impact of telecommuting on company profits they decided to rigorously evaluate its impact before making any management decisions. Ctrip conducted an experiment on 242 employees, sponsored by professors at Stanford University and Peking University. The experiment found that employees randomly assigned to work at home for 9 months increased their output by 13.5% versus the office-based control group, and their turnover rates fell by almost 50%. Adding in the savings from cutting office space telecommuting was found to have substantially reduced costs, leading Ctrip to roll this practice out across the firm.
2016-06-21 | Reiterated Rating | Bank of America | Buy | $52.00 |
2016-06-21 | Reiterated Rating | Bank of America Corp. | Buy | $52.00 |
2016-06-17 | Reiterated Rating | Nomura | Buy | $49.00 |
2016-06-17 | Reiterated Rating | Deutsche Bank | Buy | $60.00 |
2016-06-17 | Reiterated Rating | Piper Jaffray | Overweight | $50.00 |
2016-06-17 | Reiterated Rating | Piper Jaffray Cos. | Overweight | $50.00 |
2016-06-17 | Reiterated Rating | Nomura Holdings Inc. | Buy | $49.00 |
2016-06-17 | Reiterated Rating | Deutsche Bank AG | Buy | $60.00 |
2016-06-16 | Reiterated Rating | Brean Capital | Buy to Buy | $56.00 to $52.00 |
2016-06-16 | Reiterated Rating | Oppenheimer | Buy | $55.00 |
2016-06-16 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | $55.00 |
2016-06-07 | Reiterated Rating | Brean Capital | Buy | |
2016-06-02 | Reiterated Rating | Oppenheimer | Buy | |
2016-05-31 | Reiterated Rating | Brean Capital | Buy | |
2016-05-24 | Reiterated Rating | Brean Capital | Buy | |
2016-05-17 | Reiterated Rating | Brean Capital | Buy | |
2016-04-25 | Reiterated Rating | Nomura | Buy | $49.00 |
2016-04-12 | Reiterated Rating | Oppenheimer | Buy | |
2016-04-12 | Reiterated Rating | Brean Capital | Buy | $56.00 |
2016-03-17 | Lower Price Target | Stifel Nicolaus | Buy | $58.00 to $55.00 |
2016-03-17 | Lower Price Target | Brean Capital | Buy | $65.00 to $56.00 |
2016-02-23 | Initiated Coverage | JPMorgan Chase & Co. | Overweight | $50.00 |
2016-02-18 | Upgrade | Credit Agricole | Underperform to Buy | |
2016-02-18 | Upgrade | Credit Agricole SA | Underperform to Buy | |
2016-02-16 | Reiterated Rating | Summit Research | Buy | $62.50 |
2016-02-01 | Initiated Coverage | Singular Research | Sell | |
2016-01-22 | Reiterated Rating | Stifel Nicolaus | Buy | |
2016-01-22 | Initiated Coverage | Nomura | Buy | $50.00 |
2016-01-20 | Lower Price Target | Macquarie | Outperform | $71.00 to $53.00 |
2016-01-16 | Reiterated Rating | Oppenheimer | Buy | |
2016-01-14 | Lower Price Target | Oppenheimer | Outperform | $65.00 to $60.00 |
2016-01-13 | Lower Price Target | Deutsche Bank | $55.70 | |
2015-12-07 | Downgrade | HSBC | Buy to Hold | $54.00 to $55.00 |
2015-12-04 | Lower Price Target | Barclays | $62.00 | |
2015-12-04 | Lower Price Target | Barclays PLC | $62.00 | |
2015-12-01 | Reiterated Rating | Summit Research | Buy | $125.00 |
2015-11-25 | Downgrade | UBS AG | Buy to Neutral | $59.00 |
2015-11-20 | Boost Price Target | Deutsche Bank | Buy | $42.55 to $55.75 |
2015-11-20 | Boost Price Target | Barclays | Overweight | $60.00 to $62.00 |
2015-11-19 | Boost Price Target | Piper Jaffray | Overweight | $57.50 to $62.50 |
2015-11-19 | Boost Price Target | Oppenheimer | Outperform | $55.00 to $65.00 |
2015-11-19 | Boost Price Target | Stifel Nicolaus | Buy | $52.50 to $62.50 |
2015-11-19 | Lower Price Target | Brean Capital | Buy | $65.00 to $48.00 |
2015-11-13 | Downgrade | Raymond James | Strong-Buy to Outperform | $55.00 |
2015-11-13 | Downgrade | Raymond James Financial Inc. | Strong-Buy to Outperform | $55.00 |
2015-10-27 | Reiterated Rating | Oppenheimer | Outperform | $44.00 to $55.00 |
2015-10-26 | Upgrade | Goldman Sachs | Neutral to Buy | $47.00 |
2015-10-26 | Reiterated Rating | Summit Research | Buy | $61.00 |
2015-10-26 | Reiterated Rating | Piper Jaffray | Buy | |
2015-10-26 | Upgrade | Goldman Sachs Group Inc. | Neutral to Buy | $47.00 |
2015-10-12 | Reiterated Rating | Piper Jaffray | Buy | |
2015-10-07 | Upgrade | Bank of America | Neutral to Buy | $46.00 |
2015-09-21 | Reiterated Rating | Summit Research | Buy | |
2015-09-17 | Reiterated Rating | Oppenheimer | Outperform | $47.50 to $44.00 |
2015-09-15 | Reiterated Rating | Summit Research | Buy | $61.00 |
2015-09-10 | Reiterated Rating | Brean Capital | Buy | |
2015-08-28 | Upgrade | Stifel Nicolaus | Hold to Buy | $44.00 |
2015-08-14 | Reiterated Rating | Piper Jaffray | Buy | |
2015-08-05 | Reiterated Rating | Summit Research | Buy | |
2015-08-05 | Reiterated Rating | Oppenheimer | Outperform | $40.00 to $47.50 |
2015-08-04 | Boost Price Target | Deutsche Bank | Buy | $42.15 to $43.95 |
2015-08-04 | Upgrade | Morgan Stanley | Equal Weight to Overweight | $49.00 |
2015-08-04 | Reiterated Rating | Brean Capital | Buy | $48.00 |
2015-08-04 | Reiterated Rating | Piper Jaffray | Buy | $45.50 |
2015-07-23 | Reiterated Rating | Macquarie | Buy | $50.00 |
2015-07-14 | Reiterated Rating | Wunderlich | Buy | $61.00 |
2015-07-13 | Reiterated Rating | Summit Research | Buy | $61.00 |
2015-07-10 | Reiterated Rating | Stifel Nicolaus | Hold | |
2015-07-03 | Reiterated Rating | Piper Jaffray | Overweight | $45.50 |
2015-06-05 | Reiterated Rating | Summit Research | Buy | $61.00 |
2015-06-02 | Downgrade | Stifel Nicolaus | Buy to Hold | |
2015-05-26 | Boost Price Target | Summit Research | Buy | $40.00 to $61.00 |
2015-05-22 | Upgrade | Raymond James | Market Perform to Strong-Buy | $55.50 |
2015-05-18 | Initiated Coverage | Guggenheim | Buy | $45.00 |
2015-05-18 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $31.50 to $43.50 |
2015-05-16 | Reiterated Rating | Piper Jaffray | Overweight | $45.00 to $45.50 |
2015-05-14 | Upgrade | Oppenheimer | Market Perform to Outperform | $40.00 |
2015-05-14 | Reiterated Rating | Brean Capital | Buy | $35.00 to $48.00 |
2015-05-14 | Upgrade | Stifel Nicolaus | Hold to Buy | $40.00 to $44.00 |
2015-05-14 | Reiterated Rating | Summit Research | Hold | |
2015-05-14 | Upgrade | Piper Jaffray | Neutral to Outperform | $27.00 to $45.00 |
2015-05-07 | Upgrade | Barclays | Equal Weight to Overweight | $30.00 to $41.00 |
2015-04-20 | Initiated Coverage | Summit Research | Hold | $34.00 |
2015-04-10 | Reiterated Rating | Brean Capital | Buy | $35.00 |
2015-04-07 | Upgrade | Piper Jaffray | Neutral to Overweight | $27.00 to $45.00 |
2015-03-20 | Boost Price Target | Brean Capital | Buy | $32.00 to $35.00 |
2015-03-12 | Initiated Coverage | Societe Generale | Sell | |
2015-02-12 | Downgrade | Oppenheimer | Outperform to Market Perform | |
2014-11-28 | Downgrade | Morgan Stanley | Overweight to Equal Weight | $37.95 to $28.50 |
2014-11-28 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $41.00 to $28.50 |
2014-11-28 | Reiterated Rating | Oppenheimer | Outperform | $29.00 |
2014-11-26 | Lower Price Target | Brean Capital | Buy | $37.00 to $32.00 |
2014-11-26 | Downgrade | Barclays | Overweight to Equal Weight | |
2014-11-26 | Lower Price Target | Goldman Sachs | $29.50 | |
2014-11-26 | Downgrade | Raymond James | Outperform to Market Perform | $36.00 |
2014-11-21 | Initiated Coverage | HSBC | Overweight | $38.00 |
2014-11-20 | Reiterated Rating | Deutsche Bank | Buy | $38.50 to $35.00 |
2014-10-21 | Initiated Coverage | Citigroup Inc. | Buy | $35.50 |
2014-08-07 | Reiterated Rating | Deutsche Bank | Buy | $36.50 to $40.00 |
2014-08-07 | Upgrade | Credit Agricole | Underperform to Buy | $39.00 |
2014-08-01 | Downgrade | Aegis | Buy to Hold | $30.00 to $33.00 |
2014-07-31 | Boost Price Target | T.H. Capital | $36.00 | |
2014-07-31 | Reiterated Rating | Raymond James | Outperform | $33.00 to $36.00 |
2014-07-31 | Boost Price Target | Brean Capital | Buy | $30.00 to $37.00 |
2014-07-31 | Boost Price Target | Oppenheimer | Outperform | $26.50 to $37.50 |
2014-07-29 | Boost Price Target | Barclays | Overweight | $26.50 to $39.00 |
2014-06-30 | Boost Price Target | Deutsche Bank | Buy | $29.00 to $37.00 |
2014-06-25 | Downgrade | Raymond James | Strong-Buy to Outperform | |
2014-06-24 | Downgrade | Stifel Nicolaus | Buy to Hold | $29.00 |
2014-05-12 | Boost Price Target | Macquarie | $27.50 to $28.00 | |
2014-05-08 | Reiterated Rating | Morgan Stanley | Sell to Overweight | $25.25 |
2014-04-04 | Reiterated Rating | Aegis | Positive | |
2014-03-13 | Initiated | Aegis Capital | Buy | $60 |
2014-03-13 | Initiated Coverage | Aegis | Buy | $30.00 |
2014-02-13 | Lower Price Target | Oppenheimer | Outperform | $32.50 to $25.00 |
2014-02-13 | Upgrade | Morgan Stanley | Equal Weight to Overweight | $27.50 to $25.25 |
2014-01-14 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | |
2014-01-10 | Downgrade | Credit Agricole | Outperform to Underperform | |
2013-11-06 | Boost Price Target | Raymond James | Strong-Buy | $50.00 to $71.00 |
2013-11-06 | Boost Price Target | Oppenheimer | Outperform | $40.00 to $65.00 |
2013-11-06 | Boost Price Target | Brean Capital | Buy | $55.00 to $78.00 |
2013-11-06 | Boost Price Target | T.H. Capital | Buy | $64.00 to $66.00 |
2013-10-29 | Upgrade | T.H. Capital | Hold to Buy | |
2013-10-21 | Reiterated Rating | Deutsche Bank | Buy | $65.00 |
2013-10-21 | Boost Price Target | Stifel Nicolaus | Buy | $48.00 to $72.00 |
2013-09-26 | Initiated Coverage | Credit Suisse | Outperform | |
2013-09-25 | Upgrade | Deutsche Bank | Hold to Buy | $35.20 to $65.00 |
2013-08-01 | Upgrade | Stifel | Hold to Buy | $48 |
2012-02-21 | Downgrade | Brean Murray | Hold to Sell | $19 |
2011-11-14 | Downgrade | Brean Murray | Buy to Hold | |
2011-08-04 | Upgrade | Brean Murray | Hold to Buy | $43 |
2011-02-15 | Reiterated | Oppenheimer | Outperform | $54 to $50 |
2011-01-03 | Downgrade | Stifel Nicolaus | Buy to Hold | |
2010-11-17 | Initiated | Stifel Nicolaus | Buy | $60 |
2010-07-07 | Downgrade | Brean Murray | Buy to Hold | |
2010-06-24 | Initiated | Brean Murray | Buy | $51 |
2009-08-18 | Upgrade | Piper Jaffray | Neutral to Overweight | |
2009-08-05 | Reiterated | Kaufman Bros | Buy | $50 to $63 |
2009-08-05 | Downgrade | Susquehanna Financial | Positive to Neutral | |
2009-05-13 | Upgrade | Deutsche Securities | Hold to Buy | |
2009-05-12 | Upgrade | Citigroup | Sell to Buy | $16 to $40 |
2009-05-07 | Initiated | Oppenheimer | Outperform | $37 |
2008-11-14 | Reiterated | Kaufman Bros | Hold | $47 to $31 |
2016-06-21 | Reiterated Rating | Bank of America | Buy | $52.00 |
2016-06-21 | Reiterated Rating | Bank of America Corp. | Buy | $52.00 |
2016-06-17 | Reiterated Rating | Nomura | Buy | $49.00 |
2016-06-17 | Reiterated Rating | Deutsche Bank | Buy | $60.00 |
2016-06-17 | Reiterated Rating | Piper Jaffray | Overweight | $50.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CTRP 44 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Fund Advisors | 5.19M |
BlackRock Institutional Trust Company, N.A. | 4.35M |
JANUS CAPITAL MANAGEMENT LLC | 4.16M |
Standard Life Investments LTD | 4.14M |
BlackRock Group LTD | 4.04M |
Coronation Asset Management (Pty) Ltd. | 3.66M |
CAPITAL GUARDIAN TRUST CO | 2.92M |
TRILOGY GLOBAL ADVISORS LP | 1.43M |
RUSSELL FRANK CO/ | 1.42M |
PEAK6 Investments, L.P. | 1.24M |
Emerging Global Advisors, LLC | 0.66M |
Delek Group, Ltd. | 0.56M |
Chautauqua Capital Management | 0.48M |
Global X Management CO LLC | 0.45M |
BlackRock Japan Co. Ltd | 0.44M |